EMA — authorised 21 September 2018
- Marketing authorisation holder: ASTRAZENECA AB
- Status: approved
🇪🇺 Imfinzi in European Union
EMA authorised Imfinzi on 21 September 2018
Marketing authorisation
Imfinzi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Imfinzi approved in European Union?
Yes. EMA authorised it on 21 September 2018.
Who is the marketing authorisation holder for Imfinzi in European Union?
ASTRAZENECA AB holds the EU marketing authorisation.